1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NIDA Program Project Grant Applications (P01 Clinical Trial Optional) is sponsored by National Institute on Drug Abuse (NIDA).
NIDA seeks collaborative research by multi-disciplinary teams to address critical issues of neuroscience, genetics, behavior, prevention, treatment, epidemiology, etiology, medications development, health services, HIV/AIDS and co-occurring opportunistic infections (e.g., viral hepatitis C, tuberculosis, sexually transmitted infections) and associated consequences in people who use or misuse substances or have a substance use disorder, or other research areas relevant to substance use, misuse, or use disorders.
Program projects are expected to be broadly based investigative efforts with a clear, well-defined, and unifying goal or theme.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Faculty. Research institutions. Confirm the full requirements in the official notice before applying.
Applications for NIDA Program Project Grant Applications (P01 Clinical Trial Optional) are due November 20, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
NIDA Program Project Grant Applications (P01 Clinical Trial Optional) is funded by National Institute on Drug Abuse (NIDA). Verify program details on the funder's official page before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
The HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleNICHD forecast RFA-HD-28-005 (CAPSTONE), RFA-HD-28-006 (Learning Disabilities Research Centers), and RFA-HD-28-001 (Discovery Gateway) on October 20, 2026. All three are due around October 1, 2027. Here is what the incumbents hold and how challengers should prepare.
Read articleOn October 22, 2026, NIJ released three FY 2026 research solicitations: Drones as First Responders (O-NIJ-2026-172805, $3.5M, 5-6 awards, 36 months), Gangs and Organized Criminal Groups (O-NIJ-2026-172806, $3M, 5 awards, up to 60 months) and Elder Abuse, Neglect and Exploitation (O-NIJ-2026-172804, $1.8M, 2-3 awards, up to 60 months). Grants.gov is due November 30 and JustGrants December 7. The common thread is that each one rewards applicants who already have an operational law enforcement or practitioner partner. Here is how to read the three NOFOs and decide where to apply.
Read article